Search research articles
Contact Us
Filters
Showing results (481-490 of 499) with videos related to
Page
of 50
Sort By:
Nature Communications
|
February 16, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial
Tina J Hieken, Garth D Nelson, Thomas J Flotte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2024
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies
Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 17, 2012
Opioid activation of toll-like receptor 4 contributes to drug reinforcement
M R Hutchinson, A L Northcutt, T Hiranita, et al.
Water Research
|
January 8, 2021
Expanding ecological assessment by integrating microorganisms into routine freshwater biomonitoring
M Sagova-Mareckova, J Boenigk, A Bouchez, et al.
Nature Communications
|
June 9, 2021
A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech
Keith A Josephs, Joseph R Duffy, Heather M Clark, et al.
The Lancet. Global Health
|
November 29, 2020
Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study
Xin Wang, You Li, Maria Deloria-Knoll, et al.
BMJ Open
|
October 6, 2019
Early life risk factors of motor, cognitive and language development: a pooled analysis of studies from low/middle-income countries
Ayesha Sania, Christopher R Sudfeld, Goodarz Danaei, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2025
Design of Potent Menin-KMT2A Interaction Inhibitors with Improved <i>In Vitro</i> ADME Properties and Reduced hERG Affinity
Bruno D Chapsal, Jennifer R Kimbrough, Stephanie M Bester, et al.
BMJ Global Health
|
July 7, 2025
Development and validation of a novel clinical risk score to predict hypoxaemia in children with pneumonia using the WHO PREPARE dataset
Rainer Tan, Arjun Chandna, Tim Colbourn, et al.
BMJ Global Health
|
April 16, 2022
Derivation and validation of a novel risk assessment tool to identify children aged 2-59 months at risk of hospitalised pneumonia-related mortality in 20 countries
Chris A Rees, Tim Colbourn, Shubhada Hooli, et al.
Page
of 50
Search research articles
Search
Showing results (481-490 of 499) with videos related to
Sort By:
Page
of 50
Nature Communications
|
February 16, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial
Tina J Hieken, Garth D Nelson, Thomas J Flotte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2024
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies
Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 17, 2012
Opioid activation of toll-like receptor 4 contributes to drug reinforcement
M R Hutchinson, A L Northcutt, T Hiranita, et al.
Water Research
|
January 8, 2021
Expanding ecological assessment by integrating microorganisms into routine freshwater biomonitoring
M Sagova-Mareckova, J Boenigk, A Bouchez, et al.
Nature Communications
|
June 9, 2021
A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech
Keith A Josephs, Joseph R Duffy, Heather M Clark, et al.
The Lancet. Global Health
|
November 29, 2020
Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study
Xin Wang, You Li, Maria Deloria-Knoll, et al.
BMJ Open
|
October 6, 2019
Early life risk factors of motor, cognitive and language development: a pooled analysis of studies from low/middle-income countries
Ayesha Sania, Christopher R Sudfeld, Goodarz Danaei, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2025
Design of Potent Menin-KMT2A Interaction Inhibitors with Improved <i>In Vitro</i> ADME Properties and Reduced hERG Affinity
Bruno D Chapsal, Jennifer R Kimbrough, Stephanie M Bester, et al.
BMJ Global Health
|
July 7, 2025
Development and validation of a novel clinical risk score to predict hypoxaemia in children with pneumonia using the WHO PREPARE dataset
Rainer Tan, Arjun Chandna, Tim Colbourn, et al.
BMJ Global Health
|
April 16, 2022
Derivation and validation of a novel risk assessment tool to identify children aged 2-59 months at risk of hospitalised pneumonia-related mortality in 20 countries
Chris A Rees, Tim Colbourn, Shubhada Hooli, et al.
Page
of 50